We are live on
!
Find out more
TD Asset Management Portfolio holdings
AUM
$123B
1-Year Est. Return
34.51%
This Fund
S&P 500
This Quarter
Est. Return
-0.44%
1 Year Est. Return
+34.51%
3 Year Est. Return
+98.94%
5 Year Est. Return
+122.3%
10 Year Est. Return
+375.56%
AUM
$109B
AUM Growth
-$4.38B
(-3.9%)
Cap. Flow
-$1.47B
Cap. Flow
% of AUM
-1.36%
Top 10 Holdings %
Top 10 Hldgs %
24.54%
Holding
1,291
New
49
Increased
537
Reduced
574
Closed
75
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Booking.com
BKNG
|
+$323M |
| 2 |
GE Vernova
GEV
|
+$279M |
| 3 |
Agnico Eagle Mines
AEM
|
+$259M |
| 4 |
Entergy
ETR
|
+$228M |
| 5 |
Visa
V
|
+$192M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
UnitedHealth
UNH
|
+$450M |
| 2 |
NVIDIA
NVDA
|
+$325M |
| 3 |
Eaton
ETN
|
+$317M |
| 4 |
Broadcom
AVGO
|
+$288M |
| 5 |
Invesco Senior Loan ETF
BKLN
|
+$285M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Financials | 21.36% |
| 2 | Technology | 19.34% |
| 3 | Industrials | 10.57% |
| 4 | Healthcare | 9.59% |
| 5 | Consumer Discretionary | 7.87% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1126
Hertz
HTZ
$499M
| $591K | ﹤0.01% |
150,000
-180,000
| -55% | -$722K |
|
1127
UroGen Pharma
URGN
$1.86B
| $591K | ﹤0.01% |
53,400
| – | – |
|
1128
Outset Medical
OM
$84.7M
| $589K | ﹤0.01% |
+53,267
| New | +$635K |
|
1129
Bausch + Lomb
BLCO
$6.04B
| $588K | ﹤0.01% |
+40,578
| New | +$667K |
|
|
SF
1130
Stifel
SF
$12.6B
| $585K | ﹤0.01% |
9,315
-22,785
| -71% | -$1.61M |
|
|
SION
1131
Sionna Therapeutics
SION
$2.13B
| $579K | ﹤0.01% |
+55,366
| New | +$905K |
|
1132
IDEAYA Biosciences
IDYA
$3.42B
| $574K | ﹤0.01% |
35,036
-30,254
| -46% | -$645K |
|
|
LAC
1133
Lithium Americas
LAC
$1.01B
| $571K | ﹤0.01% |
211,342
+2,300
| +1% | +$6.93K |
|
1134
LCI Industries
LCII
$2.49B
| $556K | ﹤0.01% |
6,364
-81
| -1% | -$8.14K |
|
1135
Bentley Systems
BSY
$10.8B
| $550K | ﹤0.01% |
13,974
+200
| +1% | +$8.93K |
|
1136
Lyell Immunopharma
LYEL
$317M
| $540K | ﹤0.01% |
50,232
| – | – |
|
1137
Kearny Financial
KRNY
$604M
| $540K | ﹤0.01% |
86,212
| – | – |
|
1138
U-Haul Holding Co Series N
UHAL.B
$12.2B
| $540K | ﹤0.01% |
9,119
-171
| -2% | -$10.7K |
|
1139
Vanguard High Dividend Yield ETF
VYM
$80.9B
| $529K | ﹤0.01% |
4,100
| – | – |
|
1140
Celanese
CE
$4.9B
| $528K | ﹤0.01% |
9,306
-29,730
| -76% | -$1.86M |
|
1141
National Fuel Gas
NFG
$7.82B
| $523K | ﹤0.01% |
+6,600
| New | +$475K |
|
1142
British American Tobacco
BTI
$131B
| $523K | ﹤0.01% |
12,633
+139
| +1% | +$5.46K |
|
1143
Sana Biotechnology
SANA
$871M
| $519K | ﹤0.01% |
309,034
-95,314
| -24% | -$266K |
|
|
HI
1144
DELISTED
Hillenbrand
HI
| $518K | ﹤0.01% |
+21,468
| New | +$653K |
|
1145
Nurix Therapeutics
NRIX
$2.41B
| $504K | ﹤0.01% |
42,420
+3,186
| +8% | +$53.3K |
|
|
BBNX
1146
Beta Bionics
BBNX
$577M
| $488K | ﹤0.01% |
+39,876
| New | +$743K |
|
|
ORKA
1147
Oruka Therapeutics
ORKA
$5.82B
| $471K | ﹤0.01% |
45,876
-49,200
| -52% | -$614K |
|
1148
Iovance Biotherapeutics
IOVA
$1.82B
| $466K | ﹤0.01% |
139,878
-171,200
| -55% | -$883K |
|
|
OBE
1149
Obsidian Energy
OBE
$716M
| $464K | ﹤0.01% |
79,254
+76
| +0.1% | +$419 |
|
1150
iShares MSCI India ETF
INDA
$6.56B
| $462K | ﹤0.01% |
8,981
-358
| -4% | -$18K |
|
Similar funds
VAM
TD Asset Management's Q1 2025 Portfolio in Review
As of Q1 2025, TD Asset Management held 1,291 positions worth $109B, down 3.9% from $113B the previous quarter. Its ten largest holdings account for 25% of the portfolio.
TD Asset Management's Q1 2025 filing shows 49 new, 537 increased, 574 reduced and 75 closed positions. Its largest new stake was iShares MSCI South Korea ETF: 828,532 shares worth $44.8M. The largest sale was UnitedHealth, an estimated $450M.
By sector, the portfolio is most concentrated in Financials at 21% of assets, up from 21% a quarter earlier, followed by Technology and Industrials.
- TD Asset Management's largest Q1 2025 buy was iShares MSCI South Korea ETF: 828,532 shares worth $44.8M.
- TD Asset Management added most to Booking.com in Q1 2025, an estimated $323M increase.
- TD Asset Management's biggest Q1 2025 reduction was UnitedHealth, cutting an estimated $450M.
- TD Asset Management fully exited Novo Nordisk in Q1 2025, selling an estimated $51.5M.
- TD Asset Management's ten largest holdings make up 25% of its $109B portfolio in Q1 2025.
- TD Asset Management opened 49 new positions and closed 75 in Q1 2025.
- TD Asset Management's portfolio value fell 3.9% quarter-over-quarter to $109B.
Based on TD Asset Management's 13F filing for Q1 2025, filed 7 May 2025.